Iliad Biotechnologies announced it raised $3.04 Million in an initial filing from an offering of $3.04 Million
Iliad Biotechnologies announced it raised $3.04 Million in an initial filing from an offering of $3.04 Million
10/25/22, 8:44 PM
Location
Money raised
$3.04 million
Industry
biotechnology
Round Type
seed
Company Info
Location
4581 weston road
weston, florida, united states
Additional Info
ILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.